Saxagliptin + Metformin (Xr) Tablets Suppliers & Bulk Manufacturers

Available Forms: Tablets XR

Available Strengths: 2.5 mg/1000 mg, 5 mg/500 mg, 5 mg/1000 mg

Reference Brands: Kombiglyze XR®(EU & US)

Category: Diabetes

Saxagliptin + Metformin (XR) combines a DPP-4 inhibitor and a biguanide. Saxagliptin enhances incretin activity, boosting insulin and reducing glucagon. Metformin decreases hepatic glucose production. Together, they improve glycemic control with low hypoglycemia risk, weight neutrality, and convenient once-daily dosing—ideal for managing type 2 diabetes effectively. Saxagliptin + Metformin (XR) tablets is available in Tablets XR and strengths such as 2.5 mg/1000 mg, 5 mg/500 mg, 5 mg/1000 mg. Sourced from GMP-certified and ISO-compliant manufacturers, this API meets global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical formulation and commercial manufacturing, Saxagliptin + Metformin (XR) tablets is supplied in bulk quantities with complete regulatory support including DMF, COA, and MSDS.

Saxagliptin + Metformin (XR) tablets can be exported to over 30 countries across Asia, Africa, Europe, and Latin America. Flexible packaging, competitive pricing, and a verified supplier network make Pharmatradz a trusted sourcing partner for pharmaceutical companies and contract manufacturers worldwide.

Product Description: Saxagliptin + Metformin extended-release tablets are approved for type 2 diabetes treatment in both the USA and EU. In the US, they are marketed as Kombiglyze XR®, approved via an NDA and regulated under 21 CFR, with mandatory labeling for lactic acidosis risk and heart failure. Compliance with GMP and post-marketing pharmacovigilance is essential. In the EU, the product is known as Komboglyze® and is authorized via the centralized procedure. It requires a CTD format, Risk Management Plan (RMP), PSURs, and full pharmacovigilance compliance. For regulatory support and sourcing, visit PharmaTradz.com.